10 Highest Yielding Stocks
Get our free list of the highest yielding divdend growth stocks
10 Highest Yielding Stocks
Get our free list of the 10 highest yielding divdend growth stocks
Top 100
Top 100 ranked dividend stocks based on yield, dividend growth, income growth, value and return
Dividend Screener
Screen for stocks and REITS that meet your dividend investment criteria
Dividend Research
The most in depth research service of the best dividend growth stocks for divedend investors
Analyst Rating Reviews
Get the details behind the reason why a dividend paying stock was upgraded or downgraded
Dividend Growth Lists
Get our ratings on the Dividend Kings, Masters, Aristocrats and Contenders
REITs
View the top REITs that are consistently growing dividend payout year after year
8 Safe Dividend Stocks
Stocks with rock-solid dividends you can count on
Dividend Research Reports
Our comprehensive dividend research database encompasses over 600 stocks with at least five consecutive years of dividend increases. Our premium research reports average four pages in length and are updated quarterly to ensure accuracy and timeliness.
Each report provides in-depth analysis of dividend fundamentals, detailed chart analysis, earnings report summaries, analyst ratings, valuation metrics, and forward-looking insights.
Dividend Research Reports
Our comprehensive dividend research database encompasses over 600 stocks with at least five consecutive years of dividend increases. Our premium research reports average four pages in length and are updated quarterly to ensure accuracy and timeliness.
Each report provides in-depth analysis of dividend fundamentals, detailed chart analysis, earnings report summaries, analyst ratings, valuation metrics, and forward-looking insights.
Top 100 Dividend Stocks
We sort through over 800 dividend growth stocks and rank them based on Yield, dividend growth, income growth, payout ratio and return. Our database only includes stocks that have had at least 5 years of consecutive dividend increases.
Dividend Growth Lists
Our lists of dividend growth stocks features the Dividned Kings (50 years), Masters (25 years), Aristocrats (S&P 500 only w/25 years+), and the contenders. We rank each of the dividend growth stocks with our proprietary ranking system.
Dividend Lists
Our dividend growth lists include stocks that have been increasing dividends for 10 years or more. View the Kings, Masters, Aristocrats, Contenders and monthly paying dividend stocks.
Analyst Ratings
Go beyond price targets and find the reasons behind each dividend stock upgrade and downgrade.
Dividend Downgrades
Get the details behind each analyst downgrade
Mizuho Downgrades VICI Properties (VICI) to Neutral, Maintains $30 Price Target
Mizuho Downgrades VICI Properties to Neutral Mizuho analyst Haendel St. Juste has downgraded VICI Properties (NYSE: VICI) from Outperform to Neutral, maintaining the existing price target of $30 per share. The downgrade signals a shift from a bullish stance to a more...
UBS Downgrades Telefonica Brasil (VIV) From Buy to Sell
UBS Downgrades Telefonica Brasil (VIV) From Buy to Sell In a notable two-notch downgrade, UBS Group has lowered its rating on Telefonica Brasil (NYSE: VIV) from "Buy" to "Sell," skipping over a neutral rating entirely. The downgrade, issued on Wednesday, signals a...
TD Cowen Downgrades Novo Nordisk (NVO) to Hold, Sets Price Target at $42
TD Cowen Downgrades Novo Nordisk on Semaglutide Patent and Pipeline Concerns TD Cowen has downgraded Novo Nordisk A/S (NVO) from Buy to Hold, setting a price target of $42 per share. The downgrade centers on growing concerns about the company's ability to sustain its...
Dividend Upgrades
Dividend stock upgrade details and analysis
Robert W. Baird Upgrades Cintas (CTAS) to Outperform, Raises Price Target to $250
Baird Upgrades Cintas to Outperform With a $250 Price Target Robert W. Baird has upgraded Cintas Corporation (NASDAQ: CTAS) from Neutral to Outperform, raising its price target from $225 to $250. The upgrade comes at a significant moment for the business services...
JP Morgan Upgrades Oracle (ORCL) to Overweight, Sets Price Target at $210
JP Morgan Upgrades Oracle (ORCL) to Overweight with $210 Price Target JP Morgan has upgraded Oracle Corporation (NYSE: ORCL) from Neutral to Overweight, setting a price target of $210. The upgrade comes on the heels of Oracle's fiscal third-quarter earnings report,...
Argus Upgrades Novartis (NVS) to Buy, Sets Price Target at $180
Argus Upgrades Novartis to Buy, Citing Attractive Entry Point Argus has upgraded Novartis AG (NYSE: NVS) from Hold to Buy and established a price target of $180. The upgrade signals renewed confidence in the Swiss pharmaceutical giant, with the analyst firm pointing...
Analyst Ratings
Go beyond price targets and find the reasons behind each dividend stock upgrade and downgrade.
Recent Downgrades
Get the details behind each analyst downgrade
Mizuho Downgrades VICI Properties (VICI) to Neutral, Maintains $30 Price Target
Mizuho Downgrades VICI Properties to Neutral Mizuho analyst Haendel St. Juste has downgraded VICI Properties (NYSE: VICI) from Outperform to Neutral, maintaining the existing price target of $30 per share. The downgrade signals a shift from a bullish stance to a more...
UBS Downgrades Telefonica Brasil (VIV) From Buy to Sell
UBS Downgrades Telefonica Brasil (VIV) From Buy to Sell In a notable two-notch downgrade, UBS Group has lowered its rating on Telefonica Brasil (NYSE: VIV) from "Buy" to "Sell," skipping over a neutral rating entirely. The downgrade, issued on Wednesday, signals a...
TD Cowen Downgrades Novo Nordisk (NVO) to Hold, Sets Price Target at $42
TD Cowen Downgrades Novo Nordisk on Semaglutide Patent and Pipeline Concerns TD Cowen has downgraded Novo Nordisk A/S (NVO) from Buy to Hold, setting a price target of $42 per share. The downgrade centers on growing concerns about the company's ability to sustain its...
Recent Upgrades
Dividend stock upgrade details and analysis
Robert W. Baird Upgrades Cintas (CTAS) to Outperform, Raises Price Target to $250
Baird Upgrades Cintas to Outperform With a $250 Price Target Robert W. Baird has upgraded Cintas Corporation (NASDAQ: CTAS) from Neutral to Outperform, raising its price target from $225 to $250. The upgrade comes at a significant moment for the business services...
JP Morgan Upgrades Oracle (ORCL) to Overweight, Sets Price Target at $210
JP Morgan Upgrades Oracle (ORCL) to Overweight with $210 Price Target JP Morgan has upgraded Oracle Corporation (NYSE: ORCL) from Neutral to Overweight, setting a price target of $210. The upgrade comes on the heels of Oracle's fiscal third-quarter earnings report,...
Argus Upgrades Novartis (NVS) to Buy, Sets Price Target at $180
Argus Upgrades Novartis to Buy, Citing Attractive Entry Point Argus has upgraded Novartis AG (NYSE: NVS) from Hold to Buy and established a price target of $180. The upgrade signals renewed confidence in the Swiss pharmaceutical giant, with the analyst firm pointing...
Dividend Screener
Use the power of our high growth dividend database to screen for stocks that meet your criteria. Use any of the functions we use to rank dividend payers to find matches based on your investment criteria.
Dividend Screener
Use the power of our high growth dividend database to screen for stocks that meet your criteria. Use any of the functions we use to rank dividend payers to find matches based on your investment criteria.
REITs
For REITs, we prioritize recent dividend growth, which is why this list highlights the 1-year and 3-year dividend growth rates. The payout ratio is not included since REITs must distribute a minimum of 90% of their earnings to shareholders to maintain their REIT classification.
DivRank
Premium Dividend Stock Research
DivRank
Premium Dividend Stock Research